Structural changes in plasma circulating fibrinogen after moderate beer consumption as determined by electrophoresis and spectroscopy

Journal of Agricultural and Food Chemistry

Volumn 51, Issue 3, 2003, Pages 822-827

  Gorinstein, Shela ^a   Caspi, Abraham ^b   Goshev, Ivan ^c   Aksu, Sevil ^d   Salnikow, Johann ^d   Scheler, Christian ^e   Delgado licon, Efren ^f,h   Rosen, Anda ^g   Weisz, Moshe ^a   Libman, Imanuel ^b   Trakhtenberg, Simon ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b KAPLAN MEDICAL CENTER   (Israel)

^c INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

^d TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^e PROTEOME FACTORY AG   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g HEBREW UNIVERSITY   (Israel)

^h Technological Institute of   (Mexico)

Author keywords

2 DE; CD; Fibrinogen; FT IR; Moderate beer consumption; Structural changes

Indexed keywords

AMIDE; FIBRINOGEN; MINERAL WATER;

ADULT; AGED; ALPHA HELIX; ARTICLE; BEER; BETA SHEET; BLOOD; CHEMISTRY; CIRCULAR DICHROISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DRINKING BEHAVIOR; ELECTROPHORESIS; FIBRINOGEN BLOOD LEVEL; HUMAN; INFRARED SPECTROSCOPY; MALE; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN STRUCTURE; RANDOMIZED CONTROLLED TRIAL; SPECTROSCOPY; TWO DIMENSIONAL ELECTROPHORESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AGED; ALCOHOL DRINKING; BEER; CIRCULAR DICHROISM; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 0037471586     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf0206926     Document Type: Article

References (31)

1. Gorinstein, S.; Caspi, A.; Goshev, I.; Moncheva, S.; Zemser, M.; Weisz, M.; Libman, I.; Lerner, H. Z.; Trakhtenberg, S.; Martin-Belloso, O. Beer consumption and changes in stability of human serum proteins. J. Agric. Food Chem. 2001, 49, 1441-1445.
2. Gorinstein, S.; Zemser, M.; Lichman, I.; Berebi, A.; Kleipfish, A.; Libman, I.; Trakhtenberg, S.; Caspi, A. Moderate beer consumption and blood coagulation in patients with coronary artery disease. J. Intern. Med. 1997, 241, 47-51.
3. Renaud, S.; de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992, 339, 1523-1526.
4. Rimm, E. B.; Klatsky, A.; Grobbe, D.; Stampfer, M. J. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine or spirit? Br. Med. J. 1996, 312, 731-736.
5. Gorinstein, S.; Zemser, M.; Vargas-Albores, F.; Ochoa, J. L.; Parades-Lopez, O.; Scheler, C.; Salnikow, J.; Martin-Belloso, O.; Trakhtenberg, S. Proteins and amino acids in beers, their contents and relationships with other analytical data. Food Chem. 1999, 67, 71-78.
6. Gorinstein, S.; Caspi, A.; Zemser, M.; Trakhtenberg, S. Comparative contents of some phenolics in beer, red and white wines. Nutr. Res. 2000, 20, 131-139.
7. Preedy, V. R.; Siddiq, T.; Why, H.; Richardson, P. G. Ethanol toxicity and cardiac protein synthesis in vivo. Am. Heart J. 1994, 127, 1432-1439.
8. Marway, J. S.; Bateman, C. J.; Preedy, V. R. The extraction of smooth muscle contractile and noncontranctile proteins from the rats small intestine: measurement of protein synthesis and effect of ethanol toxicity. Anal. Biochem. 1993, 209, 95-103.
9. Grattagliano, I.; Vendemiale, G.; Sabba, C.; Buonamico, P.; Altomare, E. Oxidation of circulating proteins in alcoholics: role of acetaldehyde and xanthine oxides. J. Hepatol. 1996, 25, 28-36.
10. Gorinstein, S.; Caspi, A.; Libman, I.; Zemser, M.; Lerner, Z. H.; Weisz, M.; Trakhtenberg, S.; Martin-Belloso, O. Intrinsic tryptophan fluorescence of human serum proteins and related conformational changes. Protein Chem. 2000, 19, 635-640.
11. Gorinstein, S.; Caspi, A.; Rosen, A.; Goshev, I.; Zemser, M.; Weisz, M.; Aòon, M. C.; Libman, I.; Lerner. H. Z.; Trakhtenberg, S. Structure characterization of human serum proteins in solution and dry state. J. Pept. Res. 2002, 59, 71-78.
12. Mennen, L. I.; Balkau, B.; Vol, S.; Caces, E.; Eschwege, E. Fibrinogen - A possible link between alcohol consumption and cardiovascular disease? Arterioschler. Thromb. Vasc. Biol. 1999, 19, 887-892.
13. Otto, A.; Thiede, B.; Muller, E. C.; Scheler, Ch.; Wittmann-Liebold, B.; Jungblut, P. Identification of human myocardial proteins separated by two-dimensional electrophoresis using an effective sample preparation for mass spectrometry. Electrophoresis 1996, 17, 1643-1650.
14. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
15. Zemser, M.; Friedman, M.; Katzhendler, J.; Greene, L. L.; Minsky, A.; Gorinstein, S. Relationship between functional properties and structure of ovalbumin. J. Protein Chem. 1994, 13, 261-274.
16. Provencher, S. W.; Glöckner, J. Estimation of globular protein secondary structure from circular dichroism. Biochemistry 1981, 20, 33-37.
17. Henschen, A.; Lottspeich, F.; Kehl, M.; Southan, C. Covalent structure of fibrinogen. Ann. N.Y. Acad. Sci. 1983, 408, 28-43.
18. Michelsen, A. E.; Santi, C.; Holme, R.; Lord, S. T.; Simpson-Haidaris, P. J.; Solum, N. O.; Pedersen, T. M.; Brosstad, F. The charge-heterogeneity of human fibrinogen as investigated by 2D electrophoresis. Thromb. Res. 2000, 100, 529-535.
19. Azpiazi, I.; Chapman, D. Spectroscopic studies of fibrinogen and its plasmin-derived fragments. Biochim. Biophys. Acta 1992, 1119, 268-274.
20. Bolliger-Stucki, B.; Lord. S. T.; Furlan, M. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, A alpha R16C and gamma G165R. Blood 2001, 98, 351-357.
21. Burkhard, P. R.; Rodrigo, N.; May, D.; Sztajzel, R.; Sanchez, J. C.; Hochstrasser, D. F.; Shiffer, E.; Reverdin, A.; Lacroix, J. S. Assessing cerebrospinal fluid rhinorrhea: A two-dimensional electrophoresis approach. Electrophoresis 2001, 22, 1826-1833.
22. Lipinski, B.; Lipinska, I. Effect of magnesium on fibrin formation from lower molecular weight (LMW) fibrinogen. Magn. Reson. 2000, 13, 233-237.
23. Ohta, N.; Yotsuyanagi, T. Alternation of fibrinogen secondary structure by cis-diaminedichloroplatinum (II) and calcium protection. Biol. Pharm. Bull. 1993, 16, 631-634.
24. Francis, C. W.; Marder, V. J.; Martin, S. E. Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen. J. Biol. Chem. 1980, 255, 5599-5604.
25. Kuyas, C.; Haeberli, A.; Straub, P. W. Sialic acid dependent polypeptide chain heterogeneity of human fibrinogen demonstrated by two-dimensional electrophoresis. Thromb. Haemostasis 1982, 47, 19-21.
26. Gorkun, O. V.; Veklich, Y. I.; Weisel, J. W.; Lord, S. T. The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen. Blood 1997, 89, 4407-4414.
27. Henkens, R. W.; Kitchell, B. B.; Lottich, S. S.; Stein, P. J.; Williams, T. J. Detection and characterization using circular dichroism and fluorescence spectroscopy of a stable intermediate conformation formed in the denaturation of bovine carbonic anhydrase with guanidinium chloride. Biochemistry 1982, 21, 5918-5923.
28. Chmelik, J. Different rates of formation of secondary and tertiary structure during renaturation of urea-denatured human serum albumin. Collect. Czech. Chem. Commun. 1989, 54, 2542-2549.
29. Kato, K.; Matsui, T.; Tanaka, S. Quantitative estimation of α-helix coil content in bovine serum albumin by Fourier transform-infrared spectroscopy. Appl. Spectrosc. 1987, 41, 861-865.
30. Jackson, M.; Harris, P. I.; Chapman, D. Fourier Transform Infrared Spectroscopic Studies of lipids, polypeptides and proteins. J. Mol. Struct. 1989, 214, 329-355.
31. Lee, D. C.; Haris, P. I.; Charman, D.; Mitchell, R. C. Determination of protein secondary structure using factor-analysis of infrared-spectra. Biochemistry 1990, 29, 9185-9193.